Video: Humira: Clinical Trial Information for Rheumatoid Arthritis and Crohn
A review of Humira effectiveness by briefing looking at clinical trial results.
Hello and welcome to "VideoScript", presented by Drugs.com.
Today in the second of three presentations, we continue reviewing Humira, a commonly used medication in the class of drugs known as TNF blockers.
Humira is also often referred to as a biological response modifier.
We will review some of the rheumatoid arthritis and Crohn’s disease clinical trial information for Humira.
In clinical studies of Humira in early but aggressive rheumatoid arthritis, roughly 6 out of every 10 patients improved by at least 50 percent after one year.
These patients were also taking methotrexate, another drug commonly used in rheumatoid arthritis. More patients who combined methotrexate with Humira had a better response than those who used methotrexate alone.
Studies with Humira have also shown that joint damage, pain and overall daily function are dramatically improved in patients with rheumatoid arthritis. The progressive destruction of the joints can be slowed or halted.
Patients with Crohn’s disease are seeking relief from symptoms such as stomach pain, diarrhea, fatigue, and weight loss. Placebo-controlled studies with Humira showed that more than 50 percent of patients saw symptom relief at 4 weeks of treatment. A significant portion of these patients, over 20 to 30 percent, also went into remission from disease activity, meaning their signs and symptoms of Crohn’s disease improved.
Treatment of Crohn’s disease increases the chances of staying in remission.
A significant portion of patients were able to stay in clinical remission at 6 months and at 1 year.
Thank you for joining us at Drugs.com for a brief review of Humira. Please refer to our patient and professional information, drug interaction checker, and additional tools on Drugs.com.
Patients with a concern about the use of Humira should consult with their health care provider.
Visit www.drugs.com/Humira for more information
Humira: An Overview of FDA-Approved Uses and Mechanism
A brief description of common uses for Humira and how it works in rheumatoid arthritis and Crohn's disease.
Humira: Important Precautions and Side Effects
A discussion of common side effects and precautions related to Humira use.
Lyrica (pregabalin): Approved Uses and Mechanism of Action
A brief review of Lyrica (pregabalin) use in pain and seizures and its mechanism of action.
Intuniv (guanfacine): Introduction and ADHD Overview
An overview of childhood Attention Deficit Disorder Hyperactivity (ADHD) and the non-stimulant treatment Intuniv (guanfacine).
This animation shows the process of ovulation (the release a single egg cell from an ovary). Ovulation occurs though a sequence of hormonal responses. Located deep within the brain, the pituitary gland releases the hormones FSH and LH, which travel through the blood stream to the ovaries. These hormones signal the development and release a single egg cell from one of the ovaries. The sweeping motion of the fimbriae draws the egg cell through a very small space in the open body cavity into the uterine, or fallopian, tube. The egg cell will either be fertilized by sperm or will dissolve if fertilization does not take place.
Browse by Category
- Alzheimer's Disease
- Back Pain
- Children's Health
- Common Cold
- Erectile Dysfunction
- Exercise & Fitness
- Foot Health
- Heart Disease
- Irritable Bowel
- Joint Pain
- Men's Health
- Parkinson's Disease
- Sexual Health
- Smoking Cessation
- Women's Health